AbbVie Depreciation & Amortization 2011-2026 | ABBV

Annual Depreciation & Amortization AbbVie

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
762 M	764 M	752 M	778 M	803 M	666 M	464 M	471 M	425 M	425 M	417 M	383 M	388 M	525 M	508 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
803 M	383 M	569 M

Quarterly Depreciation & Amortization AbbVie

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
192 M	186 M	181 M	191 M	184 M	183 M	196 M	190 M	179 M	-	181 M	203 M	198 M	-	223 M	201 M	206 M	-	175 M	149 M	115 M	-	114 M	114 M	118 M	-	115 M	119 M	115 M	-	111 M	110 M	103 M	-	96 M	108 M	103 M	-	102 M	104 M	90 M	-	94 M	103 M	89 M	-	97 M	100 M	92 M	-	93 M	119 M	140 M	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
223 M	89 M	140 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	1.56 M	$ 20.36	-1.64 %	$ 2.57 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.81	-4.23 %	$ 4.42 M	China
Axsome Therapeutics AXSM	503 K	$ 164.64	-1.05 %	$ 8.19 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AbCellera Biologics ABCL	18.4 M	$ 3.7	-3.27 %	$ 1.11 B	Canada
Corvus Pharmaceuticals CRVS	151 K	$ 18.0	0.61 %	$ 864 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Certara CERT	75.2 M	$ 7.28	3.19 %	$ 1.17 B	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	1.07 M	$ 26.28	-2.16 %	$ 704 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Codexis CDXS	4.95 M	$ 1.01	-0.49 %	$ 74.1 M	USA
Catalyst Pharmaceuticals CPRX	375 K	$ 23.89	0.04 %	$ 2.92 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	13.6 M	$ 3.22	-3.59 %	$ 1.15 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 28.92	-0.96 %	$ 1.68 B	USA
Champions Oncology CSBR	1.6 M	$ 5.98	-1.48 %	$ 81.7 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	5.72 M	$ 2.13	-3.62 %	$ 219 M	USA
KalVista Pharmaceuticals KALV	941 K	$ 15.77	-1.81 %	$ 783 M	Britain
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	238 K	$ 4.25	2.04 %	$ 302 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	3.02 M	$ 14.2	1.9 %	$ 5.89 B	Irlanda